Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$4.8 million.

  • Jaguar Health's Enterprise Value rose 6521.08% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.8 million, marking a year-over-year increase of 6521.08%. This contributed to the annual value of -$8.8 million for FY2024, which is 3459.36% down from last year.
  • Latest data reveals that Jaguar Health reported Enterprise Value of -$4.8 million as of Q3 2025, which was up 6521.08% from -$3.3 million recorded in Q2 2025.
  • Jaguar Health's 5-year Enterprise Value high stood at -$3.2 million for Q3 2023, and its period low was -$32.2 million during Q1 2021.
  • Over the past 5 years, Jaguar Health's median Enterprise Value value was -$10.6 million (recorded in 2022), while the average stood at -$11.8 million.
  • In the last 5 years, Jaguar Health's Enterprise Value plummeted by 255432.1% in 2021 and then surged by 7975.82% in 2025.
  • Over the past 5 years, Jaguar Health's Enterprise Value (Quarter) stood at -$16.8 million in 2021, then soared by 63.31% to -$6.2 million in 2022, then dropped by 5.92% to -$6.5 million in 2023, then tumbled by 34.59% to -$8.8 million in 2024, then soared by 45.47% to -$4.8 million in 2025.
  • Its Enterprise Value stands at -$4.8 million for Q3 2025, versus -$3.3 million for Q2 2025 and -$6.6 million for Q1 2025.